Single-cell RNA sequencing, the microbiome and more offer insight into complex brain tumors
Funding expands work by consortium led by Cleveland Clinic Lerner Research Institute and CWRU
New research elucidates key role of WISP1 protein
Why most patients should explore clinical trials
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Highlights from one of the most active therapeutic clinical trials programs in the U.S.
Capecitabine-based approach shows promise in a population with few options
Algorithm reveals many features not appreciated by the unaided eye
Newly discovered signaling loop is shown to be druggable
Focus is on inhibiting action of myeloid-derived suppressor cells
Experience to date highlights need for immunotherapy focus